drugset / Trial / NCT04609514

Learn to Quit-HIV Pilot Study

NCT04609514

RandomizedParallel-groupOpen-labelTreatment

Summary

The study team will conduct a feasibility, acceptability, and preliminary efficacy trial comparing Learn to Quit-HIV (n=30) to an app based on U.S. Clinical Practice Guidelines only (NCI QuitGuide; n=30) among HIV-positive smokers. Both apps will be integrated with NRT and ongoing HIV clinical care.

Timeline

Start
2021-01-25
Primary completion
2022-06-02
Completion
2022-06-02

Drugs

EvaluationDrugModalityDoseRoute
Background Nicotine Unknown 21 mg Topical